Dolasetron and Aprindine: Interaction Details
- Dolasetron
- Anzemet
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dolasetron and Aprindine interaction:
Aprindine
We don't have a drug information page for Aprindine yet. Have a question about Aprindine? Ask a pharmacist, free →
What Happens When You Take Dolasetron With Aprindine
What can happen when they are taken together (rated Major)
An increased risk of (, , cardiac arrest)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
No formal drug interaction studies have been conducted, yet combining Class I antiarrhythmics with other agents known to lengthen the is not recommended.8 The dolasetron manufacturer, without referencing any supporting data, advises caution when dolasetron is given together with another drug capable of prolonging the QTc interval.9
The Dolasetron and Aprindine Interaction, Explained
Dolasetron (Anzemet) is used to prevent nausea and vomiting, and aprindine is a medicine that helps keep your heart rhythm steady. Both can affect the heart's electrical timing, a measure called the . Taking them together could stretch that timing more than either one alone. In rare cases that can lead to a dangerous heart rhythm problem.
This concern is based on how the drugs work, not on studies of people taking both. Still, the combination is not recommended. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor. They can review your heart history and decide whether a different nausea medicine is a better fit for you.
(). Dolasetron (via its active ) and the Class I antiarrhythmic aprindine can each prolong cardiac conduction and repolarization. Combined use may raise the risk of QT prolongation, , and cardiac arrest.
- Evidence: theoretical. No formal interaction studies exist, and the manufacturer's caution cites no data.
- Onset: unspecified.
- Severity: major.
- Management: of Class I antiarrhythmics with QT-prolonging agents such as dolasetron is not recommended. Consider a non-QT-prolonging antiemetic alternative. If use cannot be avoided, individualize and monitor closely (, electrolytes, per your protocols).
See the 9 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dolasetron and Aprindine Interact
The likely mechanism
effects on
How to Manage the Dolasetron and Aprindine Interaction
The documented advice is that these two medicines are not recommended together, because both can affect heart rhythm.
- Your care team may choose a different anti-nausea medicine, or adjust your plan and monitor you more closely if both are truly needed.
- Keep taking your medicines as prescribed until you speak with your prescriber or pharmacist. Don't stop aprindine or skip doses on your own.
- Tell your care team about any other medicines you take, and about any heart problems you have.
- Seek urgent help if you notice fainting, a racing or irregular heartbeat, or severe dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dolasetron or Aprindine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Torsades de pointes as a manifestation of mexiletine toxicity
A case of (a variant of ventricular ) has been reported in a 59-year-old male who was receiving mexiletine 100 mg orally every 6 hours.1 Once the drug was discontinued, the ventricular tachycardia did not return.
-
Report 2 · Study title
Prescribing information: Tambocor, flecainide acetate
In most patients, flecainide slows cardiac conduction, producing dose-related prolongation of the PR, QRS, and QT intervals.2
-
Report 3 · Study title
Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents
-
Report 4 · Study title
Aprindine-induced polymorphous ventricular tachycardia
Polymorphous ventricular (PVT; ) induced by aprindine has been reported, in both sustained and nonsustained forms, after oral and intravenous dosing (125 to 600 mg/day). PVT presented as and recurrent syncope.
It developed within 10 days of starting aprindine therapy and resolved within 2 to 48 hours of stopping aprindine. The returned to predrug values after aprindine was discontinued.
In some cases PVT ended spontaneously, while in others electrical cardioversion was required. In one case, may have contributed to the proarrhythmic effect. Patients with an acquired QT syndrome induced by an antiarrhythmic drug may be predisposed to aprindine-induced PVT.7
Dolasetron and Aprindine: Common Questions
How serious is the Dolasetron and Aprindine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dolasetron and Aprindine interaction managed?
The documented advice is that these two medicines are not recommended together, because both can affect heart rhythm. Your care team may choose a different anti-nausea medicine, or adjust your plan and monitor you more closely if both are truly needed. Keep taking your medicines as prescribed until you speak with your prescriber or pharmacist. Don't stop aprindine or skip doses on your own. Tell y… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dolasetron and Aprindine Interaction
Ask in your own words about taking Dolasetron and Aprindine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (9)
- Cocco G, Strozzi C, Chu D, et al: Torsades de pointes as a manifestation of mexiletine toxicity. Am Heart J 1980; 100:878-880. PubMed
- Product Information: Tambocor(R), flecainide acetate. 3M Pharmaceuticals, Northridge, CA, 1998. DailyMed
- Samanek M, Hrobonova V, & Bartakova H: Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents. Pediatr Cardiol 1987; 8:3-9. PubMed
- McDevitt DG: The clinical pharmacology of lidocaine congeners - Review of encainide, flecainide, lorcainide and tocainide. Eur Heart J 1984; 5(suppl B):63-66. DOI
- Myburgh DP, Goldman AP, & Schamroth JM: Lorcainide - an anti-arrhythmic agent for ventricular arrhythmias. S Afr Med J 1980; 57:236-239.
- Kasper W, Meinertz T, Kersting F, et al: Electrophysiological actions of lorcainide in patients with cardiac disease. J Cardiovasc Pharmacol 1979; 1:343-352. PubMed
- Scagliotti D, Strasberg B, Hai HA, et al: Aprindine-induced polymorphous ventricular tachycardia. Am J Cardiol 1982; 49:1297-1300. DOI
- Product Information: Tambocor(R), flecainide acetate. 3M Pharmaceuticals, Northridge, CA, 1998. DailyMed
- Product Information: Anzemet(R), dolasetron. Hoechst Marion Roussel, Inc. Kansas City, MO, 1997. DailyMed
Other Serious Interactions of Dolasetron and Aprindine
Also serious with Dolasetron
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PhenelzineContraindicated
- PimozideContraindicated
Also serious with Aprindine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dolasetron
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- LithiumMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 165 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.